Categories Analysis, Technology

Is Broadcom (AVGO) stock a buy ahead of earnings announcement?

The company will be reporting second-quarter results on Thursday after the bell; analysts expect earnings per share of $10.08

Broadcom, Inc. (NASDAQ: AVGO), the company that provides advanced semiconductor and infrastructure software products to top technology firms, is currently focused on enhancing its AI capabilities to meet the growing demand from clients. The chipmaker’s stock got a major boost last week after Apple, Inc. announced a multi-year deal with it for developing and supplying 5G radio frequency components and advanced connectivity components

The stock gained a whopping 20% since the announcement and is currently trading at an all-time high. Earlier, it remained unaffected by the tech selloff and has outperformed the broad market. AVGO is an attractive dividend stock, offering a yield of about 3% after the latest dividend hike. The stock has long been an investors’ favorite though some prospective buyers would find it expensive due to the high valuation.

Bullish Outlook

Broadcom looks poised to deliver strong growth going forward, supported by tailwinds like its aggressive AI push, the exceptionally healthy balance sheet – operating cash flow stood above $4 billion in the most recent quarter – and benefits from the recent Apple deal. Once completed, the planned acquisition of cloud technology company VMWare, which is currently stuck in regulatory hurdles, would allow Broadcom to expand its market share while providing enterprise customers with an expanded platform of infrastructure solutions.

From Broadcom’s Q1 2023 earnings call:

“Keep in mind that as hyper scalers, a growing portion of our switches are being deployed within their AI networks which aren’t separate from the traditional x86 CPU scale-out running existing workloads. Now, this is today. Tomorrow, with generative AI using large-scale language such as AI models with billions of parameters, we have to run thousands of AI engines in parallel, enabling large and synchronized burst of data at speeds of 400 and 800 gig. Demand works to support this massive processor density is critical, and as important as the AI engines.”

Broadcom Q1 2023 earnings infographic

Q2 Estimates

The company has been doing quite well in terms of delivering above-consensus results, with the key numbers beating estimates in every quarter in the past three years. In the first three months of the fiscal year, strong growth in Semiconductor Solutions revenue more than offset weakness in the Infrastructure Software division, resulting in a 16% growth in total revenues to $8.92 billion. At $10.33 per share, adjusted earnings were up 23% year-over-year.  

Analysts are of the view that earnings and revenue growth continued in the April quarter. They are looking for an 11% increase in second-quarter earnings to $10.08 per share on estimated revenues of $8.7 billion, which is up 7% from last year and in line with the guidance issued by the management. The report is scheduled for publication on June 1, at 4:15 PM ET.

Apple Deal

Apple has been Broadcom’s most important customer for quite some time, with about 20% of the company’s revenues coming from supplies to the latter in recent years. The multi-billion dollar deal signed by the companies last week is part of Apple’s commitment to invest about $430 billion in the US economy.

This year alone Broadcom’s shares grew an impressive 47%, and the uptrend continued this week. It started Tuesday’s trading sharply higher and gained further in the early hours of the session.

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top